Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Ra Pharmaceuticals reports interim results from phase II study of RA-101495 in PNH

Dec. 5, 2017

No Comments

Novel hemorrhagic shock model reveals time window for intervention

Dec. 4, 2017

No Comments

Daiichi Sankyo and Translational Sciences terminate TS-23 agreement

Dec. 4, 2017

No Comments

Afstyla launched in Japan for the treatment of hemophilia A

Dec. 1, 2017

No Comments

PhaseBio Pharmaceuticals obtains license to ticagrelor reversal agent

Nov. 29, 2017

No Comments

VE-2851, a promising novel thrombin inhibitor with low bleeding risk

Nov. 28, 2017

No Comments

FDA grants priority review to Dova's NDA for avatrombopag

Nov. 28, 2017

No Comments

Pharming submits sBLA for Ruconest for prevention of HAE attacks

Nov. 27, 2017

No Comments

FDA gives orphan drug status to TRM-201 for hemophilic arthropathy

Nov. 22, 2017

No Comments

BMS-986141 prevents arterial thrombosis in monkeys

Nov. 22, 2017

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Hematologic, BioWorld Science
RSS

Ra Pharmaceuticals reports interim results from phase II study of RA-101495 in PNH

Novel hemorrhagic shock model reveals time window for intervention

Daiichi Sankyo and Translational Sciences terminate TS-23 agreement

Afstyla launched in Japan for the treatment of hemophilia A

PhaseBio Pharmaceuticals obtains license to ticagrelor reversal agent

VE-2851, a promising novel thrombin inhibitor with low bleeding risk

FDA grants priority review to Dova's NDA for avatrombopag

Pharming submits sBLA for Ruconest for prevention of HAE attacks

FDA gives orphan drug status to TRM-201 for hemophilic arthropathy

BMS-986141 prevents arterial thrombosis in monkeys

Today's news in brief

Today's news in brief

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

Australia’s Celosia heads toward clinic with gene therapy for ALS

Sangamo stock plunges as Pfizer leaves hemophilia partnership

Hematologic, BioWorld Science RSS

Hematologic, BioWorld Science
RSS